Xevo MRT P10 Mass Spectrometer

Xevo MRT P10 Mass Spectrometer — Expert Summary

Significance of the topic

The Xevo MRT P10 Mass Spectrometer represents a step-change in benchtop high-resolution mass spectrometry (HRMS) by combining substantially improved MS/MS sensitivity with ultrafast acquisition rates. This capability is important for modern analytical challenges — deep lipidomics, high‑throughput proteomics, single‑cell and spatial biology, and hybrid quantitative/discovery workflows — where detection of low‑abundance species, rich fragmentation information, and fast duty cycles are essential to increase coverage, confidence and sample throughput.

Objectives and study overview

This technical overview presents the design advancements and performance benchmarks of the Xevo MRT P10. Key objectives communicated are to: increase MS/MS sensitivity relative to the predecessor Xevo MRT platform, maximize acquisition speed for both MS and MS/MS, expand flexible acquisition modes (DDA, DIA/SONAR, hybrid Tof MRM+MSE), and integrate with modern data workflows (mzML) to support multiomics and imaging applications.

Methodology

The instrument architecture leverages a multi‑reflecting time‑of‑flight (MRT) analyzer with broad innovations in ion transfer, collision cell dynamics, and acquisition electronics. Performance claims were benchmarked against the prior Xevo MRT and a leading benchtop QTOF in targeted tests (lipidomics on NIST SRM1950 human plasma using MS‑DIAL processing) and proteomics workflows (K562 digest, Evosep LC, DIA‑NN processing). Imaging capability was demonstrated using DESI XS for high spatial resolution lipid maps.

Instrumentation used

• Multi‑reflecting time‑of‑flight (MRT) mass analyzer — gridless architecture enabling a ~4 m folded flight path in a compact 0.65 m × 0.4 m package and resolving power up to ~100,000 FWHM.
• Universal Ion Source — tool‑free, interchangeable sources to cover wide analyte classes.
• StepWave™ XS ion guide — co‑joined ion guide to enhance transmission of thermally labile species and broaden compound coverage.
• Collision cell optimized for minimized transit times, fast MS1/MS2 switching and high duty cycle operations.
• Wideband Enhanced Duty Cycle (WB EDC) — to improve duty cycle across m/z 50–1200.
• Detector and acquisition system — dual‑gain amplifier with ADC‑GPU acquisition capable of >5 orders of dynamic range and an ultra‑fast, long‑life detector for consistent single‑ion responses.
• DESI XS source for mass spectrometry imaging with pixel sizes down to 10 µm and up to 100k mass resolution at acquisition speeds up to 200 Hz.
• Software/data pipeline — waters_connect platform enabling mzML export at acquisition or post‑processing; compatibility with Evosep LC systems and downstream tools such as DIA‑NN.

Main results and discussion

• Sensitivity: Reported up to 20× MS/MS sensitivity improvement (m/z 50–1200) versus the prior Xevo MRT, increasing detectability of low‑abundance analytes and expanding compound coverage.
• Lipidomics performance: Up to ~40% more confidently identified lipids compared with a competing benchtop QTOF in SRM1950 plasma (example counts provided: 1,150 lipid IDs vs 880; curated lipids 640 vs 460).
• Acquisition speed: Industry‑leading benchtop speeds with 100 Hz MS acquisition and up to 200 Hz MS/MS acquisition for DIA, DDA and targeted MS/MS workflows, enabling high sample throughput and compatibility with fast chromatography.
• Proteomics: Demonstrated deep coverage in bottom‑up workflows (example result: ~8,900 protein groups and ~91,374 precursors in optimized K562 workflows using Evosep and DIA‑NN), showing suitability for core facility multiomics.
• Advanced acquisition modes: New intelligent DDA algorithm, SONAR Pulse Acquisition Mode (a DIA approach combining sensitivity and selectivity), and a hybrid mode merging Tof MRM and MSE for simultaneous targeted quantification and untargeted discovery.
• Imaging: Combined with DESI XS, the platform achieves high spatial resolution lipid imaging (10 μm pixels) and high spectral resolution (up to 100k) at acquisition rates supporting rapid imaging (50–100 Hz demonstrated), enabling single‑cell level spatial biology investigations.

Benefits and practical applications

The Xevo MRT P10 is positioned to deliver practical advantages across several domains:

• Lipidomics and metabolomics — improved detection and identification rates for complex biological samples.
• Proteomics — higher MS/MS sensitivity and fast acquisition enable deeper peptide fragmentation coverage and greater protein identifications per unit time, supporting both discovery and higher throughput quantitative studies.
• Hybrid quantitative workflows — simultaneous targeted transitions (Tof MRM) and untargeted DIA/MSE enable flexible experiments without separate injections.
• Spatial biology and imaging — high spatial and spectral resolution with speeds that make cellular‑level imaging practical for larger tissue areas.
• High‑throughput labs — fast duty cycles and robust transfer optics reduce the trade‑off between chromatographic speed and data completeness.

Future trends and possibilities for use

Key directions where the Xevo MRT P10 capabilities are likely to have impact:

• Single‑cell and subcellular molecular profiling driven by combined high sensitivity, speed and imaging resolution.
• Integrated multiomics pipelines where rapid mzML export and compatibility with tools like DIA‑NN streamline discovery into translational workflows.
• Adoption of hybrid acquisition strategies in regulated and discovery settings to reduce sample consumption and accelerate biomarker validation.
• Further software and algorithm development (DDA/DIA scoring, deconvolution and identification workflows) to exploit the device’s high spectral fidelity and dynamic range.
• Applications in pharmacokinetics, ADME, and targeted drug quantitation leveraging fast Tof MRM transitions coupled with high‑resolution specificity.

Conclusion

The Xevo MRT P10 Mass Spectrometer extends benchtop HRMS performance by combining a multi‑reflecting TOF analyzer with optimized ion optics, fast high dynamic‑range acquisition electronics and advanced acquisition modes. Its principal strengths are markedly improved MS/MS sensitivity, industry‑leading acquisition speeds, and flexible hybrid acquisition options that together broaden analytical reach across lipidomics, proteomics, imaging and high‑throughput quantitative workflows. For laboratories demanding deeper coverage and faster throughput without sacrificing spectral quality, this platform sets a new benchmark.

References

• Waters Corporation. Xevo MRT P10 Mass Spectrometer product brochure. 2026.